BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El-Guendy NM, Helwa R, El-Halawany MS, Abdel Rahman Ali S, Tantawy Aly M, Hasan Alieldin N, Fouad SA, Saeid H, Abdel-Wahab AH. The Liver MicroRNA Expression Profiles Associated With Chronic Hepatitis C Virus (HCV) Genotype-4 Infection: A Preliminary Study. Hepat Mon 2016;16:e33881. [PMID: 27275163 DOI: 10.5812/hepatmon.33881] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Patra T, Sasaki R, Meyer K, Ray RB, Ray R. Transforming Growth Factor β Acts as a Regulatory Molecule for Lipogenic Pathways among Hepatitis C Virus Genotype-Specific Infections. J Virol 2019;93:e00811-19. [PMID: 31243135 DOI: 10.1128/JVI.00811-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Yuan S, Wu Q, Wang Z, Che Y, Zheng S, Chen Y, Zhong X, Shi F. miR-223: An Immune Regulator in Infectious Disorders. Front Immunol 2021;12:781815. [PMID: 34956210 DOI: 10.3389/fimmu.2021.781815] [Reference Citation Analysis]
3 Wei S, Xue J, Sun B, Zou Z, Chen C, Liu Q, Zhang A. miR-145 via targeting ERCC2 is involved in arsenite-induced DNA damage in human hepatic cells. Toxicology Letters 2018;295:220-8. [DOI: 10.1016/j.toxlet.2018.04.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
4 Shi W, He JJ, Mei XF, Lu KJ, Zeng ZX, Zhang YY, Sheng ZA, Elsheikha HM, Huang WY, Zhu XQ. Dysregulation of hepatic microRNA expression in C57BL/6 mice affected by excretory-secretory products of Fasciola gigantica. PLoS Negl Trop Dis 2020;14:e0008951. [PMID: 33332355 DOI: 10.1371/journal.pntd.0008951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zhang Q, Su J, Wang Z, Qi H, Ge Z, Li Z, Chen WD, Wang YD. MicroRNA-149* suppresses hepatic inflammatory response through antagonizing STAT3 signaling pathway. Oncotarget 2017;8:65397-406. [PMID: 29029439 DOI: 10.18632/oncotarget.18541] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
6 Advay S, Ahmadi A, Abdi M, Arabzadeh AM. Study of miR-29a-5p Expression in HIV Positive and HIV/HCV Co-Infected Patients in Sanandaj-Iran. Hepat Mon 2016;17. [DOI: 10.5812/hepatmon.41594] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Gong H, Zhang M, Han Y, Zhang Y, Pang J, Zhao Y, Chen B, Wu W, Qi R, Zhang T. Differential microRNAs expression profiles in liver from three different lifestyle modification mice models. BMC Genomics 2021;22:196. [PMID: 33740891 DOI: 10.1186/s12864-021-07507-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Ghazy AA, Osman EM, Rashwan EA, Gaballah AH, Mostafa H, Tawfik S. Relation between microRNA-21, transforming growth factor β and response to treatment among chronic hepatitis C patients. J Med Virol 2019;91:2166-73. [PMID: 31368531 DOI: 10.1002/jmv.25559] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
9 Elhendawy M, Abdul-Baki EA, Abd-Elsalam S, Hagras MM, Zidan AA, Abdel-Naby AY, Watny M, Elkabash IA, Salem ML, Elshanshoury M, Soliman S, Abdou S. MicroRNA signature in hepatocellular carcinoma patients: identification of potential markers. Mol Biol Rep 2020;47:4945-53. [PMID: 32430845 DOI: 10.1007/s11033-020-05521-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
10 Rashad NM, El-Shal AS, Shalaby SM, Mohamed SY. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma. Mol Cell Biochem 2018;447:125-36. [PMID: 29455432 DOI: 10.1007/s11010-018-3298-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
11 Khairy RMM, Hmmad SS, Sayed M, Ahmed HA, Esmail MAM. Serum MicroRNAs as predictors for fibrosis progression and response to direct-acting antivirals treatment in hepatitis C virus genotype-4 Egyptian patients. Int J Clin Pract 2021;75:e13954. [PMID: 33345414 DOI: 10.1111/ijcp.13954] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Chauhan R, Datzkiw D, Varma Shrivastav S, Shrivastav A. In silico identification of microRNAs predicted to regulate N-myristoyltransferase and Methionine Aminopeptidase 2 functions in cancer and infectious diseases. PLoS One 2018;13:e0194612. [PMID: 29579063 DOI: 10.1371/journal.pone.0194612] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
13 Loureiro D, Tout I, Narguet S, Benazzouz SM, Mansouri A, Asselah T. miRNAs as Potential Biomarkers for Viral Hepatitis B and C. Viruses 2020;12:E1440. [PMID: 33327640 DOI: 10.3390/v12121440] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
14 Stenfeldt C, Arzt J, Smoliga G, LaRocco M, Gutkoska J, Lawrence P. Proof-of-concept study: profile of circulating microRNAs in Bovine serum harvested during acute and persistent FMDV infection. Virol J 2017;14:71. [PMID: 28388926 DOI: 10.1186/s12985-017-0743-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
15 Aly DM, Gohar NA, Abd El-Hady AA, Khairy M, Abdullatif MM. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma. Asian Pac J Cancer Prev 2020;21:555-62. [PMID: 32102538 DOI: 10.31557/APJCP.2020.21.2.555] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
16 Demerdash HM, Hussien HM, Hassouna E, Arida EA. Detection of MicroRNA in Hepatic Cirrhosis and Hepatocellular Carcinoma in Hepatitis C Genotype-4 in Egyptian Patients. Biomed Res Int 2017;2017:1806069. [PMID: 28642869 DOI: 10.1155/2017/1806069] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
17 El-Hefny M, Fouad S, Hussein T, Abdel-Hameed R, Effat H, Mohamed H, Abdel Wahab AH. Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype-4) Egyptian patients. J Med Virol 2019;91:93-101. [PMID: 30133717 DOI: 10.1002/jmv.25294] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
18 Ye D, Zhang T, Lou G, Liu Y. Role of miR-223 in the pathophysiology of liver diseases. Exp Mol Med. 2018;50:128. [PMID: 30258086 DOI: 10.1038/s12276-018-0153-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]